OMICS Publishing Group

High Intensity Focused Ultrasound Devices Global Market Report 2022: Growing Demand for Non Invasive Therapies Drives Sector - ResearchAndMarkets.com

Retrieved on: 
Friday, October 21, 2022
Medical Devices, Health, Global High-Level Panel on Water and Peace, Degenerative disease, Application, Business Growth Fund, News, Use, Obstetrics, Gaps, Mergers and acquisitions, Collaborative partnership, Customer support, Decision-making, Midsayap Diagnostic Center and Hospital, Market share analysis, Value, Growth, Gynaecology, Strategic management, CAGR, Research, High, Investment, OMICS Publishing Group, Acquisition, Weakness, USD, Medical imaging, Retail, Hospital, Cancer

This research report categorizes the High Intensity Focused Ultrasound Devices to forecast the revenues and analyze the trends in each of the following sub-markets:

Key Points: 
  • This research report categorizes the High Intensity Focused Ultrasound Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
    Based on Application, the market was studied across Cancer, Cardiovascular Disorders, Gynecology & Obstetrics, and Urinary Disorders.
  • Based on End User, the market was studied across Diagnostic Centers, Hospitals, and Research Centers.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa.
  • The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market.

Parks Associates: 22% of US Internet Households use Their Smart Watches and Other Wearables for Safety Purposes

Retrieved on: 
Friday, October 21, 2022
Adoption, Future, Conference, OMICS Publishing Group, British Parking Association, Table, Research, Back to the Future (1989 video game), Digital media, Technology, Smartwatch, Exercise, Health, SMB, OTT, Interview, Internet, App Store (iOS/iPadOS), Solution, Consumer, Mobile phone, Consumer electronics

DALLAS, Oct. 21, 2022 /PRNewswire/ -- New research from Parks Associates reveals that the top use cases for wearables involve health and activity tracking, while 22% of US internet households (25 million households) using their wearables for safety reasons. The international research firm's study Smart Watches and Wearables Market Assessment reveals adoption of smart watches increased from 16% of US internet households in 2020 to 29% in 2021.

Key Points: 
  • The international research firm's study Smart Watches and Wearables Market Assessment reveals adoption of smart watches increased from 16% of US internet households in 2020 to 29% in 2021.
  • "Connected health has become mainstream with smart watches leading the way," said Kristen Hanich , Research Director, Parks Associates.
  • The adoption of wearables leads the connected health category, with smart watches the number one most adopted connected health product overall.
  • Parks Associates' Smart Product Market Assessments provide a comprehensive and deep analysis of a single smart product market.

NeuroSigma Announces Commercial Launch of The Monarch eTNS® System for the Treatment of Pediatric ADHD at Annual Meeting of the American Academy of Child and Adolescent Psychiatry

Retrieved on: 
Monday, October 17, 2022
Monarch, Caregiver, American Academy of Child and Adolescent Psychiatry, Diagnosis, Anticonvulsant, Attention deficit hyperactivity disorder, ADHD, Patient, Depression, AACAP, United, OMICS Publishing Group, American Academy, GLOBE, Telephony, FDA, Pharmaceutical industry, Medicine, Child

LOS ANGELES, Oct. 17, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. , aLos Angeles-based bioelectronics company, today announced the commercial launch of The Monarch eTNS System at the annual meeting of the American Academy of Child and Adolescent Psychiatry (AACAP) in Toronto.

Key Points: 
  • LOS ANGELES, Oct. 17, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. , aLos Angeles-based bioelectronics company, today announced the commercial launch of The Monarch eTNS System at the annual meeting of the American Academy of Child and Adolescent Psychiatry (AACAP) in Toronto.
  • The Monarch eTNS System is a bioelectronic medical device that uses external trigeminal nerve stimulation (eTNS) to treat neurological and neuropsychiatric disorders.
  • In 2019, the Monarch eTNS System became the first-ever medical device cleared by FDA for treating pediatric ADHD.
  • The company is commercializing the Monarch eTNS System, which is the first non-drug treatment for pediatric ADHD cleared by the FDA.

Global Cell Free Protein Expression Market Trajectory & Analytics, 2022-2026: Rising Incidence of Cancer and the Demand for Biologics Spur the Adoption of Cell Free Protein Extraction - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 6, 2022
Biotechnology, Pharmaceutical, Health, Stem Cells, Protein, Efficiency, Isotope, Growth, CAGR, Research, D, Technology, OMICS Publishing Group, Mutation, Overalls, Glycosylation, COVID-19, Interaction, Fine chemical, Pet, Dietary supplement

The "Cell Free Protein Expression - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cell Free Protein Expression - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Another application for which the approach is considered ideal is mammalian protein expression with appropriate glycosylation and native PTMs (Post-translational Modifications).
  • Researchers also use cell-free protein expression for analyzing components needed for protein stability, degradation and folding.
  • This segment currently accounts for a 24.1% share of the global Cell Free Protein Expression market.

Parks Associates Announces Chris White as Director, Smart Home and Energy Research

Retrieved on: 
Wednesday, October 5, 2022
Adoption, College, Future, VP, Conference, OMICS Publishing Group, British Parking Association, BBA, MBA, Back to the Future (1989 video game), Digital media, Technology, American University, EVS, Marketing, Health, SMB, OTT, Energy, Internet, App Store (iOS/iPadOS), Data analysis, Solution, Consumer, Renewable energy, Consumer electronics, Research

DALLAS, Oct. 5, 2022 /PRNewswire/ -- Parks Associates announced today the promotion of Chris White to Director, Smart Home and Energy Research, at Parks Associates. Chris joined the firm as a senior analyst and will now lead the efforts for the company's research products and services in the smart home areas, including custom work and data analysis leveraging Parks Associates' quarterly surveys of more than 10,000 US internet households.

Key Points: 
  • DALLAS, Oct. 5, 2022 /PRNewswire/ --Parks Associates announced today the promotion of Chris White to Director, Smart Home and Energy Research, at Parks Associates.
  • Parks Associates publishes research studies, trackers, and custom work on the emerging technology areas and has researched the home automation, security, and energy industries since the late 1980s.
  • "The role of technology continues to grow for consumers, and it is exciting to help shape the research in the smart home and energy areas," said Chris White , Director, Research of Parks Associates.
  • He leverages this background in marketing research and data gathering to contribute to the design of Parks Associates' consumer surveys.

Avance Clinical Wins International Health Award for Biotech CRO Services

Retrieved on: 
Wednesday, September 28, 2022
OGTR, FDA, IBM, Growth, Review, International health, National Premier Leagues South Australia, Technology, Medidata Solutions, CRO, Vaccine, Office of the Gene Technology Regulator, Drug development, Government, GMO, Research, AU, Export award, Frost & Sullivan, OMICS Publishing Group, EMA, Watson (computer), Pharmaceutical industry, Fine chemical, EU, Oracle

SYDNEY, AU, Sept 28, 2022 - (ACN Newswire) - Avance Clinical, the leading Australian-based biotech CRO with US operations has won the South Australian Premier's Export Awards - International Health category.

Key Points: 
  • SYDNEY, AU, Sept 28, 2022 - (ACN Newswire) - Avance Clinical, the leading Australian-based biotech CRO with US operations has won the South Australian Premier's Export Awards - International Health category.
  • CEO Yvonne Lungershausen said Avance Clinical is now the leading Australian-based biotech CRO with US operations.
  • Avance Clinical has been recognised for the past two consecutive years with the prestigious Frost & Sullivan CRO Best Practices Award.
  • Avance Clinical, a Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient for the past two years, has been providing CRO services in the region for more than 24 years.

Parks Associates: 68% of Internet Households Watch NFL Games Throughout the Season

Retrieved on: 
Wednesday, September 14, 2022
Consumer, LG Electronics, Health, SVOD, Software, OMICS Publishing Group, Twitter, Internet, OTT, NFL Network, British Parking Association, Future, Senior, Universal, NBCUniversal, Industry, SMB, The Walt Disney Company, NFL, CBS, App Store (iOS/iPadOS), Metrology, Technology, VIZIO, Electronics, Solution, Tracker, NFL Films, Copyright, Interview, Research, QuickPlay, Conference, Marketing, Amazon, Digital media, NBC, Back to the Future (1989 video game), FPT Software, Amusement arcade, Video game, Fandango, Brightcove, Video

DALLAS, Sept. 14, 2022 /PRNewswire/ -- The latest update of Parks Associates' OTT Video Market Tracker analyzes the NFL+ launch and the market context for the NFL's streaming service, as part of the Tracker's ongoing analysis of top industry and consumer trends in the OTT video space. Parks Associates consumer research finds 68% of internet households watch NFL games throughout the season, making football the most widely watched sport in the US. NFL+ aims to capitalize on that popularity with a subscription (SVOD) service that offers access to live local and primetime games, NFL Network shows on-demand, and access to the NFL Films archives, although some fans have been frustrated with the viewing experience in the preseason.

Key Points: 
  • Parks Associates consumer research finds 68% of internet households watch NFL games throughout the season, making football the most widely watched sport in the US.
  • NFL+ aims to capitalize on that popularity with a subscription (SVOD) service that offers access to live local and primetime games, NFL Network shows on-demand, and access to the NFL Films archives, although some fans have been frustrated with the viewing experience in the preseason.
  • "The NFL+ service included out-of-market preseason games but viewable only on mobile devices," said Eric Sorensen , Senior Contributing Analyst, Parks Associates.
  • "Now, with the start of the NFL season, many fans are frustrated with local blackouts on the service.

Parks Associates: EV Owners Charge at Home Most Often, But 61% Also Charge Regularly at Work

Retrieved on: 
Tuesday, September 6, 2022
Digital media, Consumer, OTT, Technology, Research, Solution, Original equipment manufacturer, App Store (iOS/iPadOS), British Parking Association, Conference, International, Internet, SMB, EV, OMICS Publishing Group, Experience, EVS, Industry, Health, Back to the Future (1989 video game), Future, Adoption, CMO, Renewable energy, Mobile phone, Sales (accounting)

DALLAS, Sept. 6, 2022 /PRNewswire/ -- Parks Associates research finds that while electric vehicle (EV) owners charge at home most often, 61% also charge regularly at work, and over 50% charge while at a restaurant, highlighting the demand for and need to expand charging infrastructure as more households acquire EVs.

Key Points: 
  • The research firm will highlight its consumer EV research during the industry webinar, "Eliminating EV Barriers: Future Proofing the Experience," hosted on Thursday, September 8, in cooperation with Particle.io.
  • Currently, only 6% of US households own an electric vehicle today, but 19% of US internet households are likely to purchase an EV in the next year.
  • "EV momentum is real, and so is the opportunity for utilities and connected home players," said Elizabeth Parks , President and CMO, Parks Associates.
  • "Major auto OEMs have committed to a conversion to fully electrified fleets across the next 10 years, so the EV revolution has already begun.

Avance Clinical Announces North American CRO Acquisition to Expand Later Phase Services for Biotechs

Retrieved on: 
Tuesday, September 6, 2022
EMA, Technology, Associate, Lists of people executed in the United States, Time, Vaccine, OGTR, Culture, OMICS Publishing Group, Government, Office of the Gene Technology Regulator, Investment, AU, FDA, GMO, CRO, Medidata Solutions, Knowledge, Acquisition, IBM, Drug development, Review, Frost & Sullivan, Fine chemical, Medicine, Pharmaceutical industry, Oracle

SYDNEY, AU, Sept 6, 2022 - (ACN Newswire) - Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the acquisition of CRO partner company C3 Research Associates, enabling biotech clients a seamless journey from early phase to later phase studies.

Key Points: 
  • SYDNEY, AU, Sept 6, 2022 - (ACN Newswire) - Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the acquisition of CRO partner company C3 Research Associates, enabling biotech clients a seamless journey from early phase to later phase studies.
  • The combined Avance Clinical Australia, New Zealand, and North American operations deliver a unique GlobalReady drug development model for biotechs.
  • This strong relationship made C3 Research Associates a natural acquisition choice for Avance Clinical's expansion plans into North America.
  • Avance Clinical offers pre-clinical services with their experienced ClinicReady team right through to later phase clinical services leveraging significant Government incentive rebates of up to 43.5% and rapid start-up regulatory processes.

Avance Clinical Sponsors Biotech Company of the Year Awards at Informa Pharma Intelligence Awards 2022

Retrieved on: 
Monday, August 29, 2022
EMA, Watson (computer), Technology, Vaccine, OGTR, OMICS Publishing Group, Government, Biotechnology, Office of the Gene Technology Regulator, Cros, FDA, Year, GMO, CRO, Medidata Solutions, Growth, IBM, Drug development, Review, Frost & Sullivan, Fine chemical, Oracle

It is a credit to our customer-focused team for delivering world-leading CRO services for biotechs which has been recognized by the Informa Pharma Intelligence award judges.

Key Points: 
  • It is a credit to our customer-focused team for delivering world-leading CRO services for biotechs which has been recognized by the Informa Pharma Intelligence award judges.
  • Avance Clinical has a global reputation for agile clinical solutions to support accelerated clinical development for our international biotech clients.
  • Avance Clinical has been recognised for the past two consecutive years with the prestigious Frost & Sullivan CRO Best Practices Award.
  • Avance Clinical uses state-of-the-art technology and gold standard systems across all functional areas to provide clients with the most effective processes.